1. A repeat‐dose thorough QT study of inhaled fluticasone furoate/vilanterol combination in healthy subjects. (March 2014) Authors: Kempsford, Rodger; Allen, Ann; Kelly, Kathryn; Saggu, Parminder; Crim, Courtney Journal: British journal of clinical pharmacology Issue: Volume 77:Number 3(2014:Mar.) Page Start: 466 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Brief Report: Impact of COVID-19 on Cabotegravir Plus Rilpivirine Long-Acting Dosing Across 6 Ongoing Global Phase IIb and III Clinical Trials. (1st October 2022) Authors: Czarnogorski, Maggie; Benn, Paul; McCoig, Cindy; Nwafor, Toyin; Griffith, Sandy; Sutton, Ken; Harrington, Conn; Saggu, Parminder; Yague, Itziar; Williams, Will; Español, Carlos M.; Goodchild, Jessica; Fricker, Jane; Patel, Parul; D'Amico, Ronald Journal: Journal of acquired immune deficiency syndromes Issue: Volume 91:Number 2(2022) Page Start: 157 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗